Compounded topical peptides for skin and hair Compounded topical peptides differ from over-the-counter peptide serums in two ways: prescription concentrations (1 to 3 percent GHK-Cu versus 0.05 to 0.1 percent OTC) and provider-customized formulas
S., Navarini, A., Okazaki, A., Iliopoulos, O., Nmeth, I., Fisher, D
In New Jersey, the medical board has stated that only physicians should perform radiofrequency treatments, and we have to agree
For mature scars, other interventions may be more appropriate, though BPC-157 could potentially support remodeling if used in conjunction with treatments that re-activate healing (such as microneedling or laser resurfacing)
The future of retatrutide research Retatrutide is still in active clinical development by Eli Lilly under multiple Phase 3 trial programs